Carolyn D. Runowicz - Concepedia

Author

Carolyn D. Runowicz

Albert Einstein College of Medicine ORCID

Also Known As

Atul Vashist, C D Runowicz, C Runowicz, C. D. Runowicz, C. Runowicz, C.D. Runowicz, CAROLYN D. RUNOWICZ, CD Runowicz, Carol Runowicz, Carolyn D Runowicz

242

Publications

18.1K

Citations

H-Index

117

Concepts

All Affiliations

Albert Einstein College of Medicine Montefiore Medical Center National Cancer Institute Florida International University UConn Health

About

Carolyn D. Runowicz is an author at Albert Einstein College of Medicine specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	58	9.4K
2	Public Health	16	18	6.4K
3	Health Sciences	2	2	839
4	Education	1	1	36
5	Biochemistry	1	1	24

Carolyn D. Runowicz

Publications

13.1K

Citations

H-Index

Page 1

	Year	Citations
Ovarian cancer statistics, 2018 Lindsey A. Torre, Britton Trabert, Carol DeSantis, CA A Cancer Journal for Clinicians Reproductive SciencesOvarian Cancer IncidenceOvarian Cancer StatisticsEpidemiology Of CancerGynecology	2018	3.6K
American Cancer Society Guidelines for the Early Detection of Cancer Robert A. Smith, Vilma Cokkinides, Andrew C. von Eschenbach, CA A Cancer Journal for Clinicians Cancer ManagementEpidemiology Of CancerCancer RegistrationCancer Risk FactorsPreventive Medicine	2002	1.6K
Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, JNCI Journal of the National Cancer Institute	2005	1.3K
American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection R A Smith, Andrew C. von Eschenbach, Richard C. Wender, CA A Cancer Journal for Clinicians American Cancer SocietyMedical ImagingUpdate 2001Cancer ScreeningEarly Detection Guidelines	2001	824
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Cancer Prevention Research Serm RaloxifeneSelective Estrogen-receptor ModulatorSurgical OncologyOncologyBreast Oncology	2010	637
Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Obstetrical & Gynecological Survey Surgical OncologyBreast OncologyGynecologyPharmacotherapyOther Disease Outcomes	2006	330
American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction Kala Visvanathan, Rowan T. Chlebowski, Patricia A. Hurley, Journal of Clinical Oncology	2009	286
Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. Avi I. Einzig, Peter H. Wiernik, Jill Sasloff, Journal of Clinical Oncology	1992	268
Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles Alexandra Rodzinski, Rakesh Guduru, Ping Liang, Scientific Reports	2016	258
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update Kala Visvanathan, Carol J. Fabian, Elissa Bantug, Journal of Clinical Oncology	2019	192

Page 1